POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $66,393 | -33.0% | 9,954 | -9.0% | 0.04% | -32.2% |
Q2 2023 | $99,107 | -8.5% | 10,939 | -26.6% | 0.06% | -1.7% |
Q1 2023 | $108,338 | -28.0% | 14,902 | -27.8% | 0.06% | -24.1% |
Q4 2022 | $150,385 | +28.5% | 20,629 | +36.3% | 0.08% | +68.1% |
Q3 2022 | $117,000 | +14.7% | 15,135 | +0.7% | 0.05% | +23.7% |
Q2 2022 | $102,000 | – | 15,029 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 2,312,523 | $18,431,000 | 4.36% |
GREAT POINT PARTNERS LLC | 2,060,000 | $16,418,000 | 3.97% |
RA Capital Management | 9,003,018 | $71,754,000 | 1.57% |
JOHNSON & JOHNSON | 1,000,000 | $7,970,000 | 1.51% |
BVF INC/IL | 3,367,826 | $26,842,000 | 1.07% |
Boxer Capital, LLC | 2,500,000 | $19,925,000 | 1.02% |
Sio Capital Management, LLC | 377,684 | $3,010,000 | 1.00% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,014,408 | $24,025,000 | 0.73% |
SILVERARC CAPITAL MANAGEMENT, LLC | 204,679 | $1,631,000 | 0.68% |
Atom Investors LP | 60,103 | $479,000 | 0.22% |